Wall Street brokerages expect that Aspen Aerogels, Inc. (NYSE:ASPN – Get Rating) will post earnings per share (EPS) of ($0.47) for the current quarter, according to Zacks. Five analysts have provided estimates for Aspen Aerogels’ earnings. The lowest EPS estimate is ($0.58) and the highest is ($0.35). Aspen Aerogels posted earnings of ($0.22) per share in the same quarter last year, which would suggest a negative year over year growth rate of 113.6%. The firm is scheduled to issue its next quarterly earnings report before the market opens on Monday, January 1st.
On average, analysts expect that Aspen Aerogels will report full-year earnings of ($1.87) per share for the current financial year, with EPS estimates ranging from ($1.98) to ($1.73). For the next year, analysts expect that the company will report earnings of ($1.17) per share, with EPS estimates ranging from ($1.63) to ($0.70). Zacks’ earnings per share averages are an average based on a survey of research firms that follow Aspen Aerogels.
Aspen Aerogels (NYSE:ASPN – Get Rating) last released its quarterly earnings data on Thursday, February 17th. The construction company reported ($0.50) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.30) by ($0.20). The business had revenue of $31.48 million during the quarter, compared to the consensus estimate of $35.71 million. Aspen Aerogels had a negative return on equity of 33.70% and a negative net margin of 30.50%. During the same period last year, the business posted ($0.23) earnings per share.
NYSE:ASPN traded down $0.17 during trading hours on Monday, hitting $26.25. The stock had a trading volume of 293,512 shares, compared to its average volume of 376,059. The company has a 50 day simple moving average of $30.04 and a two-hundred day simple moving average of $41.54. Aspen Aerogels has a one year low of $16.33 and a one year high of $65.99. The firm has a market capitalization of $872.39 million, a price-to-earnings ratio of -22.06 and a beta of 1.77.
In other Aspen Aerogels news, major shareholder Koch Industries Inc bought 1,791,986 shares of the firm’s stock in a transaction that occurred on Monday, March 28th. The shares were bought at an average price of $27.90 per share, for a total transaction of $49,996,409.40. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Robert M. Gervis bought 135,870 shares of the firm’s stock in a transaction that occurred on Tuesday, March 22nd. The stock was acquired at an average price of $33.12 per share, for a total transaction of $4,500,014.40. The disclosure for this purchase can be found here. 13.30% of the stock is owned by company insiders.
Several hedge funds have recently added to or reduced their stakes in the business. State Board of Administration of Florida Retirement System increased its position in shares of Aspen Aerogels by 2.0% in the third quarter. State Board of Administration of Florida Retirement System now owns 9,401 shares of the construction company’s stock valued at $433,000 after acquiring an additional 180 shares during the period. UBS Group AG increased its position in shares of Aspen Aerogels by 0.5% in the third quarter. UBS Group AG now owns 83,503 shares of the construction company’s stock valued at $3,842,000 after acquiring an additional 393 shares during the period. Metropolitan Life Insurance Co NY increased its position in shares of Aspen Aerogels by 6.5% in the third quarter. Metropolitan Life Insurance Co NY now owns 6,529 shares of the construction company’s stock valued at $300,000 after acquiring an additional 400 shares during the period. Banque Cantonale Vaudoise purchased a new position in shares of Aspen Aerogels in the third quarter valued at about $31,000. Finally, Advisor Group Holdings Inc. increased its position in shares of Aspen Aerogels by 70.9% in the fourth quarter. Advisor Group Holdings Inc. now owns 1,847 shares of the construction company’s stock valued at $92,000 after acquiring an additional 766 shares during the period. Hedge funds and other institutional investors own 83.46% of the company’s stock.
Aspen Aerogels Company Profile (Get Rating)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production.
- Get a free copy of the StockNews.com research report on Aspen Aerogels (ASPN)
- Banking On Bank Of America
- Major Shareholder Bets Big On Nielson Holdings plc
- Tapestry Stock is a Value Play Down Here
- Levi Straus Stock Ready to Buy the Dip
- Bed Bath & Beyond Stock Ready to Scale Into
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.